I’m now over at Bluesky as @brianreid.bsky.social. I really don’t need another social account to tend to, so most of my posting will remain at LinkedIn. But the community at
Cost Curve News: Everything Drug Pricing, Every Day
The Cost Curve is the industry-leading source for news, commentary, and analysis on pharmaceutical pricing, access, policy, and reimbursement. Our daily Cost Curve newsletter is an agenda-setting look at the issues driving the biopharmaceutical industry.
What We Deliver
- Daily Updates: Our daily newsletter delivers a regular and reliable overview of what matters. Now.
- Comprehensive Coverage: No other publication does as deep, as often, on issues related to pricing and access, looking at the issue from a commercial, reputational, patient, and policy perspective.
- Expert Commentary: Expert opinions and perspectives designed to give readers a look around the corner at what’s coming next.
- Data and Trends: Access to proprietary data based on Cost Curve News’ unique approach to tracking industry milestones and external reactions.
Join our community of decisionmakers who rely on Cost Curve News to shape their strategies, advocacy efforts, and decision-making in the ever-evolving pharmaceutical landscape.
Suggested Posts
Nothing Found! Ready to publish your first post? Get started here.
Popular
Most Viewed
- CMS Patient-Focused Listening Session Transcripts (1,380)
- Working Out the Strange Math and Weird Consequences of IRA Inflation Penalties (834)
- More IRA Lawsuits Coming, PhRMA Chief Predicts (683)
- Bernie Sanders Wants to Talk to CEOs About US vs ROW Pricing. Bring It On, I Say. (656)
- Looking Under the Hood at the Pricing Approach for the New Zepbound Obesity Med (615)
Archives
- November 2024 (12)
- October 2024 (19)
- September 2024 (19)
- August 2024 (17)
- July 2024 (18)
- June 2024 (15)
- May 2024 (17)
- April 2024 (21)
- March 2024 (18)
- February 2024 (18)
- January 2024 (18)
- December 2023 (18)
- November 2023 (16)
- October 2023 (21)
- September 2023 (6)